ROYAL BANK OF CANADA - ESSA PHARMA INC ownership

ESSA PHARMA INC's ticker is and the CUSIP is 29668H104. A total of 11 filers reported holding ESSA PHARMA INC in Q2 2017. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
ROYAL BANK OF CANADA ownership history of ESSA PHARMA INC
ValueSharesWeighting
Q1 2018$8,000
-11.1%
42,050
-1.4%
0.00%
Q4 2017$9,000
+200.0%
42,630
+277.3%
0.00%
Q3 2017$3,000
-50.0%
11,300
-2.8%
0.00%
Q2 2017$6,000
-68.4%
11,626
+87.5%
0.00%
Q1 2017$19,000
+35.7%
6,2000.0%0.00%
Q4 2016$14,000
+16.7%
6,200
+47.6%
0.00%
Q3 2016$12,0000.0%4,2000.0%0.00%
Q2 2016$12,000
-14.3%
4,2000.0%0.00%
Q1 2016$14,000
-78.5%
4,200
-72.5%
0.00%
Q4 2015$65,000
+6400.0%
15,260
+7530.0%
0.00%
Q3 2015$1,0002000.00%
Other shareholders
ESSA PHARMA INC shareholders Q2 2017
NameSharesValueWeighting ↓
Clarus Ventures, LLC 2,121,212$1,167,0001.07%
Omega Fund Management, LLC 1,696,969$933,0000.58%
AWM Investment Company, Inc. 1,440,269$792,0000.14%
Eventide Asset Management 2,719,410$1,308,0000.08%
ACUTA CAPITAL PARTNERS, LLC 442,000$242,0000.07%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 1,416,230$779,0000.04%
TORONTO DOMINION BANK 400$00.00%
BANK OF MONTREAL /CAN/ 1,000$1,0000.00%
Citadel Advisors 18,863$10,0000.00%
UBS Group AG 6,000$3,0000.00%
View complete list of ESSA PHARMA INC shareholders